 AngioDynamics Inc NASDAQ: ANGO reports break-even in 4Q of 2021 with adjusted EPS of 0.00, a turnaround from EPS of 0.06 posted a year ago. The Company witnessed the pressure from COVID-19 gradually alleviate over the year, and business is now trending close to normalized run rates. 